Pascal Goetghebeur

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study

Pascal Goetghebeur, Rebecca Dias · Psychopharmacology · 2008 · 99 citations

Attention Control, Psychiatry, Cognitive Performance +10

The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia

Roger S. McIntyre, David G. Daniel, Eduard Vieta et al. · CNS Spectrums · 2022 · 53 citations · Full text

Luvadaxistat: A Novel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia

Rosa Fradley, Pascal Goetghebeur, David J. Miller et al. · Neurochemical Research · 2023 · 48 citations · Full text

L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition

Zheng Huang, Rebecca Dias, Tom R. Jones et al. · Biochemical Pharmacology · 2007 · 30 citations

Asthma, Allergy, Medicine +10

Chronic infusion of PCP via osmotic mini-pumps: A new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance

Christian Spang Pedersen, Pascal Goetghebeur, Rebecca Dias · Journal of Neuroscience Methods · 2009 · 26 citations

Psychiatry, Neurophysiology, Medicine +12